SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10989856
Source:
http://linkedlifedata.com/resource/pubmed/id/10989856
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0025361
,
umls-concept:C0026056
,
umls-concept:C0030971
,
umls-concept:C0085633
,
umls-concept:C0205161
,
umls-concept:C0599946
pubmed:issue
9
pubmed:dateCreated
2001-1-22
pubmed:abstractText
To determine the effects of midazolam, 30 ngxmL(-1), on altered perception, mood, and cognition induced by ketamine.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8701709
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anesthetics, Dissociative
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Anxiety Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Ketamine
,
http://linkedlifedata.com/resource/pubmed/chemical/Midazolam
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0832-610X
pubmed:author
pubmed-author:FuhrmanT MTM
,
pubmed-author:HurstH EHE
,
pubmed-author:LansingP SPS
,
pubmed-author:LippmannS BSB
,
pubmed-author:SheppardR ARA
,
pubmed-author:SuzukiMM
,
pubmed-author:TolanM MMM
,
pubmed-author:TsuedaKK
pubmed:issnType
Print
pubmed:volume
47
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
866-74
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:10989856-Adult
,
pubmed-meshheading:10989856-Affect
,
pubmed-meshheading:10989856-Anesthetics, Dissociative
,
pubmed-meshheading:10989856-Anti-Anxiety Agents
,
pubmed-meshheading:10989856-Blood Pressure
,
pubmed-meshheading:10989856-Cognition Disorders
,
pubmed-meshheading:10989856-Double-Blind Method
,
pubmed-meshheading:10989856-Heart Rate
,
pubmed-meshheading:10989856-Humans
,
pubmed-meshheading:10989856-Ketamine
,
pubmed-meshheading:10989856-Male
,
pubmed-meshheading:10989856-Midazolam
,
pubmed-meshheading:10989856-Middle Aged
,
pubmed-meshheading:10989856-Neuropsychological Tests
,
pubmed-meshheading:10989856-Perception
,
pubmed-meshheading:10989856-Psychomotor Performance
,
pubmed-meshheading:10989856-Sleep Stages
,
pubmed-meshheading:10989856-Thinking
pubmed:year
2000
pubmed:articleTitle
Midazolam attenuates ketamine-induced abnormal perception and thought process but not mood changes.
pubmed:affiliation
Department of Anesthesiology, University of Louisville School of Medicine, KY 40292, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial